Trial Profile
Study evaluating rivaroxaban administration for atrial fibrillation
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 May 2018
Price :
$35
*
At a glance
- Drugs Rivaroxaban (Primary)
- Indications Embolism and thrombosis; Stroke
- Focus Therapeutic Use
- 09 May 2018 New trial record
- 12 Mar 2018 Results assessing real-world prescribing and patient adherence to dietary requirements presented at the 67th Annual Scientific Session of the American College of Cardiology